Technologies to Reduce Caregiver Burden for Informal Caregivers of People With Dementia
NCT ID: NCT02733939
Last Updated: 2019-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2016-03-31
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-Home Technology for Dementia Caregivers
NCT03828383
Developing and Evaluating a Digital Intervention Aiming to Support Informal Caregivers of People With Dementia
NCT07248241
Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
NCT05961319
What Are my Options to Stay Safe at Home: Technology For Aging at Home
NCT04267484
The Clinical Evaluation of Continuous Assistance Offered to Older People Living Independently.
NCT01218373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled trial aims to evaluate the effects of new technologies on caregiver burden by reducing the time spent in supervision. The trial builds on previous promising results from the UP-TECH project in Italy (https://clinicaltrials.gov/ct2/show/NCT01700556) . The technologies used in TECH@HOME will include similar, but improved, home monitoring kits potentially leading to a greater impact on caregivers' caring conditions. In addition, while the UP-TECH study did not allow the researchers to estimate the impact of the technology as a "stand-alone" intervention (the monitoring kits were only given in combination with case-management support), TECH@HOME will overcome this limitation thanks to the possibility to compare a group of technology users vs. non-users. Results from this intervention in dementia care in Sweden hold the potential to inform regional and national policy makers in Sweden and beyond.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Technology intervention
Patients randomized in the intervention group will receive a technical home monitoring kit for 12 months. The kits will be composed of a control unit and a set of sensors that immediately notify caregivers, through their phones, of any potential risks for the person with dementia. The kit will have home leaving sensors, bed occupancy sensors, smoke and water leak sensors, automatic lights, and other interactive functions. These devices will be connected to a single-board microcontroller that will transmit alarm messages to the caregivers in case of need.
Home monitoring kit
The home monitoring kits notify the caregivers about potentially dangerous situations, such as when the person with dementia:
* leaves the home without notice, since this might occur in a moment of disorientation;
* leaves a water tap open;
* forgets something on the stove;
* gets out of bed during the night and doesn't come back within a certain time interval;
* never goes to the bathroom in 24 hours;
* never opens refrigerator door in 24 hours.
Depending on the personal choice of the study participants, the kit will also :
* automatically turn on a light to help avoid a fall during the night;
* alert the caregiver when the temperature in the house falls or rises excessively;
* act as burglar alarm in some areas of the home.
Usual care
Patients receiving usual care, as provided to people with dementia in Southern Sweden can vary. In the target area, people with dementia usually receive comparable pharmaceutical treatment depending on the dementia type, as prescribed by a general practitioner or a specialist at a memory clinic. The social worker from the Municipality ("Biståndshandläggaren") where the person resides, together with the district nurse, have a meaningful role in tailoring the care plan by mediating access to other care services such as respite care homes, home help and (dementia) nurse home visits. Use of such services depends on the specific needs of the person with dementia, which can also be unrelated to dementia, but rather dependent upon concomitant health and social issues.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home monitoring kit
The home monitoring kits notify the caregivers about potentially dangerous situations, such as when the person with dementia:
* leaves the home without notice, since this might occur in a moment of disorientation;
* leaves a water tap open;
* forgets something on the stove;
* gets out of bed during the night and doesn't come back within a certain time interval;
* never goes to the bathroom in 24 hours;
* never opens refrigerator door in 24 hours.
Depending on the personal choice of the study participants, the kit will also :
* automatically turn on a light to help avoid a fall during the night;
* alert the caregiver when the temperature in the house falls or rises excessively;
* act as burglar alarm in some areas of the home.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A score between 10 and 24 on the Mini-Mental State Examination (MMSE-SR);
* A score between 1 and 5 in the Global Deterioration Scale (GDS)
* Community dwelling;
* Able to speak and understand Swedish;
* Have at least one informal caregiver.
* Lack of informed consent;
* Unwillingness to use technological devices for home assistance and safety;
* Presence of severe diseases associated with a life expectancy of less than 6 months;
* Being already enrolled in another ongoing trial.
Exclusion Criteria
* Being fully dependent on caregiver support for the Activities of Daily Living;
* Presence of severe diseases associated with a life expectancy of less than 6 months;
* Intention of moving to institutionalized care during the study period;
* Unwillingness to use technological devices for home assistance and safety;
* Being enrolled in another ongoing trial;
* Substance use disorder (DSM-5).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Chiatti, PhD
Role: PRINCIPAL_INVESTIGATOR
Lund University and Italian National Institute on Health and Ageing (INRCA)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memory Clinic, Hospital of Ängelholm
Ängelholm, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Malmgren Fange A, Schmidt SM, Nilsson MH, Carlsson G, Liwander A, Dahlgren Bergstrom C, Olivetti P, Johansson P, Chiatti C; TECH@HOME Research Group. The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trial. Trials. 2017 Feb 9;18(1):63. doi: 10.1186/s13063-017-1796-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-4913
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.